A Master of Science degree in the management of drug development will be granted upon completion of at least 32 units of course work. The program is offered on both a full-time and part-time basis, and courses are also available in distance formats. Course requirements normally include a minimum of three courses concerned with translational aspects of medical product development. Recommended courses to satisfy this core requirement include RSCI 531, RSCI 532, PSCI 664 or CXPT 609. The program must also include a minimum of one course in each of: regulatory science, quality assurance, clinical research, business and statistics. Students should develop a specific plan of study in consultation with graduate advisers before beginning the program.